Pediatric cancer research and biotech innovation by Day One Biopharmaceuticals

  • Andreas Kristo
  • 01.06.2026
Day One Biopharmaceuticals invites attendees to connect at major industry meeting
Day One Biopharmaceuticals is encouraging engagement from participants at an industry meeting, inviting attendees to visit their booths numbered 36155 and 12079. The company aims to foster ...
  • Andreas Kristo
  • 29.05.2026
Day One Biopharmaceuticals joins ASCO26 to promote cancer care innovation
Day One Biopharmaceuticals is taking part in ASCO26, a leading annual gathering in the oncology community. The company is engaging with attendees at booths 36155 and 12079 to share updates on ...
  • Andreas Kristo
  • 22.05.2026
Day One Biopharmaceuticals to present new adenoid cystic carcinoma data at ASCO26 on June 1
Day One Biopharmaceuticals will present new clinical data for its investigational medicine targeting adenoid cystic carcinoma (ACC) during an oral presentation at ASCO26 on June 1. The company ...